Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
National Beverage
FIZZ
$2.95B
| $21.8M | ﹤0.01% |
461,421
+291
| +0.1% | +$14.1K |
|
1902
Krystal Biotech
KRYS
$9.21B
| $21.8M | ﹤0.01% |
320,176
+34,343
| +12% | +$2.4M |
|
1903
GoodRx Holdings
GDRX
$1.07B
| $21.7M | ﹤0.01% |
603,571
+249,875
| +71% | +$9.22M |
|
|
DHC
1904
Diversified Healthcare Trust
DHC
$2.13B
| $21.7M | ﹤0.01% |
5,197,939
+157,688
| +3% | +$651K |
|
1905
AMERISAFE
AMSF
$564M
| $21.7M | ﹤0.01% |
363,918
+5,391
| +2% | +$342K |
|
1906
BioLife Solutions
BLFS
$1.57B
| $21.7M | ﹤0.01% |
488,006
+133,124
| +38% | +$4.69M |
|
|
XM
1907
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $21.6M | ﹤0.01% |
565,804
+70,783
| +14% | +$2.49M |
|
1908
Dillards
DDS
$9.57B
| $21.6M | ﹤0.01% |
119,582
-3,558
| -3% | -$459K |
|
1909
First Bancorp
FBNC
$2.64B
| $21.6M | ﹤0.01% |
528,455
+1,105
| +0.2% | +$47.7K |
|
1910
Vanda Pharmaceuticals
VNDA
$315M
| $21.6M | ﹤0.01% |
1,004,362
+38,948
| +4% | +$697K |
|
1911
First Busey Corp
BUSE
$2.6B
| $21.6M | ﹤0.01% |
873,885
+29,045
| +3% | +$746K |
|
1912
The Bancorp
TBBK
$2.96B
| $21.5M | ﹤0.01% |
935,000
-6,810
| -0.7% | -$160K |
|
1913
ePlus
PLUS
$2.45B
| $21.5M | ﹤0.01% |
495,312
+11,980
| +2% | +$572K |
|
|
BWIN
1914
Baldwin Insurance Group
BWIN
$2.85B
| $21.4M | ﹤0.01% |
803,775
+61,149
| +8% | +$1.66M |
|
|
RPT
1915
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $21.4M | ﹤0.01% |
1,648,696
+56,623
| +4% | +$719K |
|
1916
S&T Bancorp
STBA
$1.85B
| $21.4M | ﹤0.01% |
683,439
+32,528
| +5% | +$1.08M |
|
1917
OFG Bancorp
OFG
$2.24B
| $21.4M | ﹤0.01% |
966,452
+40,647
| +4% | +$966K |
|
|
TEN
1918
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $21.3M | ﹤0.01% |
1,103,619
+186,419
| +20% | +$2.79M |
|
1919
Southside Bancshares
SBSI
$972M
| $21.3M | ﹤0.01% |
557,177
-4,441
| -0.8% | -$181K |
|
1920
FirstService
FSV
$6.61B
| $21.3M | ﹤0.01% |
124,775
+12,389
| +11% | +$2.03M |
|
|
SHYF
1921
DELISTED
The Shyft Group
SHYF
| $21.2M | ﹤0.01% |
567,557
+17,775
| +3% | +$670K |
|
1922
Arcus Biosciences
RCUS
$3.47B
| $21.2M | ﹤0.01% |
771,554
+60,032
| +8% | +$1.71M |
|
1923
Mercury Insurance
MCY
$5.94B
| $21.2M | ﹤0.01% |
325,877
-4,824
| -1% | -$306K |
|
1924
JFrog
FROG
$9.98B
| $21.2M | ﹤0.01% |
464,823
+349,769
| +304% | +$15.8M |
|
|
DM
1925
DELISTED
Desktop Metal, Inc.
DM
| $21.1M | ﹤0.01% |
183,702
+90,037
| +96% | +$11.8M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.